New York Health Care, Inc. provides services of registered nurses and paraprofessionals to patients at their homes in the United States. Its services are supplied principally to contracts with healthcare institutions and governmental agencies. The company also engages in the identification, licensing, and development of treatments for various gastrointestinal disorders, such as pouchitis, irritable bowel syndrome, crohn's disease, ulcerative colitis, celiac disease, and c. difficile infections. It offers PROBACTRIX, which restores the microbial balance within the gastrointestinal tract by selective displacement of pathogenic bacteria and prevention of their recolonization. New York Health Care was founded in 1983 and is headquartered in Brooklyn, New York.